Cerebrolysin
Clinical evidence — Human trial data existsWhat it is
A porcine-brain-derived peptide preparation used in some countries for neurological conditions, with a mixed human evidence base.
Cerebrolysin is a porcine-brain-derived peptide preparation used for neurological conditions in some countries, with a mixed/contested human evidence base. Supplied as a ready-made solution.
Research context
Studied in relation to:
- Neuroprotection/cognitive research
Points in its favour in the literature:
- Approved and used in several countries
- Human trial data exists
Caveats and unknowns:
- Evidence contested/mixed
- Animal-derived
- Not approved everywhere
Handling & reference data
Route in published researchReady-made solution for intramuscular or intravenous use in clinical settings.
Published clinical / research context (not instructions)Clinical courses ~5–30 mL/day depending on protocol (clinician-led).
Storage (lyophilised)Store per supplier label; protect from light.
Reconstituted solutionUse ampoules per label; do not store opened ampoules.
Worked reconstitution example (arithmetic only)Supplied as a ready-made solution — no reconstitution needed. Follow the supplier's label.
Available research formats
| Strength | SKU |
|---|---|
| 60mg (6 vials) | CBL60 |
Current pricing (THB with USD/GBP conversion) is shown live in the catalogue, which also has a transparent U-100 reconstitution calculator.